| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $92.9M | -38.9% |
| Cost of Revenue | $13.4M | -12.8% |
| R&D Expense | $16.7M | -40.5% |
| SG&A Expense | $78.9M | -18.4% |
| Operating Income | -$46.5M | +59.3% |
| Pre-tax Income | -$46.7M | +53.8% |
| Income Tax | $66K | -72.4% |
| Net Income | -$46.8M | +53.8% |
| EPS (Basic) | -$2.62 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $271.9M | -10.0% |
| Accounts Receivable | $4.9M | -17.7% |
| Current Assets | $303.2M | -6.6% |
| Total Assets | $374.3M | -5.4% |
| Current Liabilities | $65.9M | +32.2% |
| Long-term Debt | $125.7M | +1.4% |
| Total Liabilities | $201.2M | +8.6% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.1M | +90.1% |
| Capital Expenditures | $668K | -95.0% |
| Investing Cash Flow | -$1.4M | -100.8% |
| Financing Cash Flow | -$21.7M | +85.6% |
| Free Cash Flow | -$7.7M | +90.9% |
| +46.0% |
| EPS (Diluted) | -$2.62 | +46.0% |
| Stockholders' Equity |
| $173.0M |
| -17.8% |